Clinical Trial Update: Magnesium Sulfate Versus Ipratropuim Bromide in Acute Exacerbation of Chronic Obstructive Pulmonary Disease [Phase 3]

View source ↗

Summary

Phase 3 trial comparing magnesium sulfate to ipratropium bromide in acute exacerbations of chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)
• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: University of Monastir | Conditions: COPD Exacerbation | Phase 3 | Status: COMPLETED